What is the difference between AOD-9604 and CJC 1295 Ipamorelin?

AOD-9604 is typically discussed in research for fat-metabolism/lipolysis-related signaling. By contrast, CJC-1295 (a GHRH analog) and Ipamorelin (a ghrelin receptor agonist) are researched as growth hormone secretagogues—compounds that stimulate growth hormone release pathways.

In simple terms: AOD-9604 research tends to focus on fat signaling endpoints, while CJC-1295/Ipamorelin research focuses on endocrine (GH/IGF-1–related) signaling and downstream markers.

Disclaimer: The statements are for informational purposes only and not intended to diagnose, treat, or cure any disease. All products mentioned are for research purposes only and not for human use.